MedTrace Logo

Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline

NCT00203112 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2011-04-12

No results posted yet for this study

Summary

This study investigates the add-on effect of oral minocycline in subjects treated with daily injection of Copaxone. Copaxone and minocycline are thought to have differential modes of actions that may complement each other in treating MS symptoms.

Conditions

  • Relapse Remitting Multiple Sclerosis

Interventions

DRUG

glatiramer acetate with minocycline

Subcutaneous injection glatiramer acetate 20mg, with oral minocycline 100mg

DRUG

Glatiramer acetate with placebo

Subcutaneous injection glatiramer acetate 20mg, with oral placebo

Sponsors & Collaborators

  • Teva Branded Pharmaceutical Products R&D, Inc.

    lead INDUSTRY

Principal Investigators

  • Jean Godin, MD · Teva Neuroscience Canada

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2006-06-30
Completion
2006-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00203112 on ClinicalTrials.gov